Innogenetics Nv HC Wellington AP 233/00

Link copied
Case Copied 10 min read

IN THE HIGH COURT OF NEW ZEALAND
WELLINGTON REGISTRY AP 233/00

UNDER The Trade Marks Act 1953

IN THE MATTER of an appeal from the decision of the Assistant Commissioner of Trade Marks dated 3 October 2000.

AND

IN THE MATTER of New Zealand Trade Mark application number 271332

BETWEEN INNOGENETICS NV
Appellant

Hearing: 1 May 2001

Counsel: P C Dengate Thrush for the Appellant

Judgment: 14 May 2001

ORAL JUDGMENT OF GODDARD J

[1] This is an appeal from a decision by the Commissioner of Trade Marks (“the Commissioner”) dated 22 April 1999.

[2] The application No. 271332 was for “LIA”, in Class 5, for pharmaceuticals; diagnostic products for medical use; hygienic products; substances for medical use. The application, which was made on 6 January 1997, stated that the mark was to be used by the proprietors (being the applicant). On 15 January 1997 the Principal Trade Mark Examiner wrote on behalf of the Commissioner to the applicant’s solicitors advising:

“I do not consider the mark acceptable for registration because it is not distinctive in relation to the goods. The letters LIA have a number of meanings in the field of medicine. See attached copy of the Acronyms, Initialisms & Abbreviations Dictionary.

Registration of this trade mark could disadvantage other business people who may legitimately want to use the mark.”

[3] Following further formalities, the appellant’s solicitors wrote seeking Part A registration on the basis that “LIA” was a pronounceable and meaningless word and should meet the requirements for registration. That advice was not however accepted by the Commissioner. On 21 January 1998, formal objection to registration in either Part A or Part B was advised to the appellant’s solicitors on the following grounds:

“. . . the application is directed to a combination of letters not in themselves able to be distinctive.

The mark is not inherently adapted to distinguish the applicants goods from those goods of other proprietors in the same trading channel, nor is it capable of distinguishing the applicants goods from those other traders in the agricultural machinery/implement field. As such the applicant is not entitled to the grant of monopoly which prevents other traders from using the letters LIA in the marketplace.”

[4] The appellant’s solicitors responded, refuting these stated grounds of objection. On 3 October 2000 the Commissioner’s decision was delivered by the Assistant Commissioner of Trade Marks refusing the application.

The Legislation

[5] The relevant sections are found in that part of the Trade Mark Act 1953 dealing with Registrability and Validity of Registrations. Section 14 provides for distinctiveness as a requisite for registration in Part A. Section 14(1)(c), (d) and (2) specifically provide as follows:

“(1) In order for a trade mark (other than a certification trade mark) to be registrable in part A of the register, it must contain or consist of at least one of the following essential particulars:

. . .

(c) An invented word or invented words:

(d) A word or words having no direct reference to…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Innogenetics Nv HC Wellington AP 233/00 and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2001] NZHC 324
Decision Date

CaseChat Overview and Summary

Innogenetics NV, the appellant, appealed a decision by the Commissioner of Trade Marks, which was upheld by the Assistant Commissioner of Trade Marks, to refuse the registration of the trade mark "LIA" for pharmaceuticals and diagnostic products. The Court was required to decide whether "LIA" was a registrable trade mark under the Trade Marks Act 1953. The key legal issues were whether "LIA" was a word, whether it was distinctive and capable of distinguishing goods, and whether its registration would likely cause deception or confusion. The court found that "LIA" could be considered a word, was distinctive and capable of distinguishing the appellant's goods, and its registration would not likely cause deception or confusion. The Assistant Commissioner's decision was flawed in its approach to the statutory requirements for registration. The appeal was allowed and the application was granted. Innogenetics NV was also entitled to costs, which were allowed in Category 2B.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.